A mom was overjoyed when she learned a drug could save her baby's life. Then she learned it cost $2 million.

A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would ...
Kalkine Media

Sarepta Therapeutics (NASDAQ:SRPT) Nasdaq Index Tracks Biotech Advancements

Sarepta Therapeutics (NASDAQ:SRPT) leads in genetic therapies, contributing to ongoing discussions surrounding the nasdaq ...
Clinical Trials Arena on MSN

Sarepta terminates Hansa-partnered gene therapy combination trial

Sarepta and Hansa formed the partnership in 2020 to determine if Idefirix could broaden the patient population for Elevidys.
Seeking Alpha

What’s behind Sarepta’s gene therapy deaths?

Three patient deaths linked to neuromuscular drugs developed by Sarepta Therapeutics (NASDAQ:SRPT) have drawn regulatory scrutiny on the viral vector used in the company’s gene therapy platform ...
STAT

A mother’s perspective on Sarepta’s gene therapy halt

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
WSLS 10

Sarepta will resume gene therapy shipments after FDA review of recent patient death

WASHINGTON – Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a ...
WFMZ-TV

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

FILE - The name and logo of Sarepta Therapeutics is displayed on the company's headquarters, Monday, July 28, 2025, in Cambridge, Mass. WASHINGTON (AP) — The Food and Drug Administration said Friday ...
Seeking Alpha

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

WASHINGTON (AP) — Drugmaker Sarepta Therapeutics (SRPT) said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the ...